Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes by Gañán-Gómez, I, Wei, Y, Starczynowski, D T, Colla, S, Yang, H, Cabrero-Calvo, M, Bohannan, Z S, Verma, A, Steidl, U, Garcia-Manero, G

Get full text

IRAK signalling in cancer by Rhyasen, G W, Starczynowski, D T

Get full text

Epistasis between TIFAB and miR-146a: neighboring genes in del(5q) myelodysplastic syndrome by Varney, M E, Choi, K, Bolanos, L, Christie, S, Fang, J, Grimes, L H, Maciejewski, J P, Inoue, J-I, Starczynowski, D T

Get full text

Epistasis between TIFAB and miR-146a: neighboring genes in del(5q) myelodysplastic syndrome by Varney, M E, Choi, K, Bolanos, L, Christie, S, Fang, J, Grimes, H L, Maciejewski, J P, Inoue, J-I, Starczynowski, D T

Get full text

Erratum: Epistasis between TIFAB and miR-146a: neighboring genes in del(5q) myelodysplastic syndrome by Varney, M E, Choi, K, Bolanos, L, Christie, S, Fang, J, Grimes, H L, Maciejewski, J P, Inoue, J-I, Starczynowski, D T

Get full text

Epistasis between TIFAB and miR-146a: neighboring genes in del by Choi, K, Fang, J, Varney, M E, Maciejewski, J P, Bolanos, L, Grimes, H L, Inoue, J-I, Christie, S, Starczynowski, D T

Get full text

Mouse gene targeting reveals an essential role of mTOR in hematopoietic stem cell engraftment and hematopoiesis by Guo, F., Zhang, S., Grogg, M., Cancelas, J. A., Varney, M. E., Starczynowski, D. T., Du, W., Yang, J.-Q., Liu, W., Thomas, G., Kozma, S., Pang, Q., Zheng, Y.

Get full text

Polymeric FAD used as enzyme-friendly mediator in lactate detection by Leonida, Mihaela D, Starczynowski, Daniel T, Waldman, Riva, Aurian-Blajeni, Benedict

Get full text

Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis by Arcipowski, Kelly M, Bulic, Marinka, Gurbuxani, Sandeep, Licht, Jonathan D

Get full text

Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in mice by Lamothe, Betty, Lai, Yunju, Hur, Lana, Orozco, Natalia Martin, Wang, Jing, Campos, Alejandro D, Xie, Min, Schneider, Michael D, Lockworth, Cynthia R, Jakacky, Jared, Tran, Diep, Ho, Michael, Dawud, Sity, Dong, Chen, Lin, Hui-Kuan, Hu, Peter, Estrov, Zeev, Bueso-Ramos, Carlos E, Darnay, Bryant G

Get full text

The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity by Thompson, Ryan C, Vardinogiannis, Iosif, Gilmore, Thomas D

Get full text

TIFAB Regulates USP15-Mediated p53 Signaling during Stressed and Malignant Hematopoiesis by Niederkorn, Madeline, Hueneman, Kathleen, Choi, Kwangmin, Varney, Melinda E., Romano, Laurel, Pujato, Mario A., Greis, Kenneth D., Inoue, Jun-ichiro, Meetei, Ruhikanta, Starczynowski, Daniel T.

Get full text

Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML by Bennett, Joshua, Ishikawa, Chiharu, Agarwal, Puneet, Yeung, Jennifer, Sampson, Avery, Uible, Emma, Vick, Eric, Bolanos, Lyndsey C., Hueneman, Kathleen, Wunderlich, Mark, Kolt, Amal, Choi, Kwangmin, Volk, Andrew, Greis, Kenneth D., Rosenbaum, Jan, Hoyt, Scott B., Thomas, Craig J., Starczynowski, Daniel T.

Get full text

TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity by Muto, Tomoya, Guillamot, Maria, Yeung, Jennifer, Fang, Jing, Bennett, Joshua, Nadorp, Bettina, Lasry, Audrey, Redondo, Luna Zea, Choi, Kwangmin, Gong, Yixiao, Walker, Callum S., Hueneman, Kathleen, Bolanos, Lyndsey C., Barreyro, Laura, Lee, Lynn H., Greis, Kenneth D., Vasyliev, Nikita, Khodadadi-Jamayran, Alireza, Nudler, Evgeny, Lujambio, Amaia, Lowe, Scott W., Aifantis, Iannis, Starczynowski, Daniel T.

Get full text

The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation by Yeaton, Anna, Cayanan, Geraldine, Loghavi, Sanam, Dolgalev, Igor, Leddin, Emmett M, Loo, Christian E, Torabifard, Hedieh, Nicolet, Deedra, Wang, Jingjing, Corrigan, Kate, Paraskevopoulou, Varvara, Starczynowski, Daniel T, Wang, Eric, Abdel-Wahab, Omar, Viny, Aaron D, Stone, Richard M, Byrd, John C, Guryanova, Olga A, Kohli, Rahul M, Cisneros, G Andrés, Tsirigos, Aristotelis, Eisfeld, Ann-Kathrin, Aifantis, Iannis, Guillamot, Maria

Get full text

Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations by Choudhary, Gaurav S, Pellagatti, Andrea, Agianian, Bogos, Smith, Molly A, Bhagat, Tushar D, Gordon-Mitchell, Shanisha, Sahu, Srabani, Pandey, Sanjay, Shah, Nishi, Aluri, Srinivas, Aggarwal, Ritesh, Aminov, Sarah, Schwartz, Leya, Steeples, Violetta, Booher, Robert N, Ramachandra, Murali, Samson, Maria, Carbajal, Milagros, Pradhan, Kith, Bowman, Teresa V, Pillai, Manoj M, Will, Britta, Wickrema, Amittha, Shastri, Aditi, Bradley, Robert K, Martell, Robert E, Steidl, Ulrich G, Gavathiotis, Evripidis, Boultwood, Jacqueline, Starczynowski, Daniel T, Verma, Amit

Get full text

Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML by Barreyro, Laura, Sampson, Avery M., Hueneman, Kathleen, Choi, Kwangmin, Christie, Susanne, Ramesh, Vighnesh, Wyder, Michael, Wang, Dehua, Pujato, Mario, Greis, Kenneth D., Huang, Gang, Starczynowski, Daniel T.

Get full text

Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia by Barreyro, Laura, Sampson, Avery M, Ishikawa, Chiharu, Hueneman, Kathleen M, Choi, Kwangmin, Pujato, Mario A, Chutipongtanate, Somchai, Wyder, Michael, Haffey, Wendy D, O'Brien, Eric, Wunderlich, Mark, Ramesh, Vighnesh, Kolb, Ellen M, Meydan, Cem, Neelamraju, Yaseswini, Bolanos, Lyndsey C, Christie, Susanne, Smith, Molly A, Niederkorn, Madeline, Muto, Tomoya, Kesari, Santosh, Garrett-Bakelman, Francine E, Bartholdy, Boris, Will, Britta, Weirauch, Matthew T, Mulloy, James C, Gul, Zartash, Medlin, Stephen, Kovall, Rhett A, Melnick, Ari M, Perentesis, John P, Greis, Kenneth D, Nurmemmedov, Elmar, Seibel, William L, Starczynowski, Daniel T

Get full text

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes by Zeidan, Amer M., Bewersdorf, Jan Philipp, Buckstein, Rena, Sekeres, Mikkael A., Steensma, David P., Platzbecker, Uwe, Loghavi, Sanam, Boultwood, Jacqueline, Bejar, Rafael, Bennett, John M., Borate, Uma, Brunner, Andrew M., Carraway, Hetty, Churpek, Jane E., Daver, Naval G., Della Porta, Matteo, DeZern, Amy E., Efficace, Fabio, Fenaux, Pierre, Figueroa, Maria E., Greenberg, Peter, Griffiths, Elizabeth A., Halene, Stephanie, Hasserjian, Robert P., Hourigan, Christopher S., Kim, Nina, Kim, Tae Kon, Komrokji, Rami S., Kutchroo, Vijay, List, Alan F., Little, Richard F., Majeti, Ravi, Nazha, Aziz, Nimer, Stephen D., Odenike, Olatoyosi, Padron, Eric, Patnaik, Mrinal M., Roboz, Gail J., Sallman, David A., Sanz, Guillermo, Stahl, Maximilian, Starczynowski, Daniel T., Taylor, Justin, Xie, Zhuoer, Xu, Mina, Savona, Michael R., Wei, Andrew H., Abdel-Wahab, Omar, Santini, Valeria

Get full text

FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome by Schieber, Michael, Marinaccio, Christian, Bolanos, Lyndsey C., Haffey, Wendy D., Greis, Kenneth D., Starczynowski, Daniel T., Crispino, John D.

Get full text